|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q67516855
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000226.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q67516855
|
|
024
|
|
|
‡a
0000-0003-4204-803X
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q67516855
|
|
046
|
|
|
‡f
19550000
|
|
100
|
0 |
|
‡a
J F Nicolas
‡9
ast
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Jean Francois Nicolas
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
J F Nicolas
‡c
investigador
‡9
es
|
|
400
|
0 |
|
‡a
Jean-François Nicolas
‡c
chercheur
‡9
fr
|
|
400
|
0 |
|
‡a
J F Nicolas
‡c
wetenschapper
‡9
nl
|
|
400
|
0 |
|
‡a
Жан-Франсуа Николя
‡9
ru
|
|
670
|
|
|
‡a
Author's 7th Drug hypersensitivity meeting: part two.
|
|
670
|
|
|
‡a
Author's [A case for diagnosis: superficial pemphigus presenting as giant keratotic lesions]
|
|
670
|
|
|
‡a
Author's A Perspective on the Interplay of Ultraviolet-Radiation, Skin Microbiome and Skin Resident Memory TCRαβ+ Cells.
|
|
670
|
|
|
‡a
Author's Activation of Flucloxacillin-Specific CD8+ T-Cells With the Potential to Promote Hepatocyte Cytotoxicity in a Mouse Model.
|
|
670
|
|
|
‡a
Author's [Adhesion molecules: their potential implication for dermatology]
|
|
670
|
|
|
‡a
Author's Allergen penetration through the skin.
|
|
670
|
|
|
‡a
Author's Allergic contact dermatitis
|
|
670
|
|
|
‡a
Author's [Allergic contact dermatitis: how to re-induce tolerance?]
|
|
670
|
|
|
‡a
Author's Allergic delayed drug hypersensitivity is more frequently diagnosed in drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome than in exanthema induced by beta-lactam antibiotics
|
|
670
|
|
|
‡a
Author's Allergic reaction to methylprednisolone
|
|
670
|
|
|
‡a
Author's Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF- Alpha antibody (adalimumab)
|
|
670
|
|
|
‡a
Author's Alpha interferon treatment in atopic dermatitis
|
|
670
|
|
|
‡a
Author's Ambroxol-induced toxicoderma
|
|
670
|
|
|
‡a
Author's Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug
|
|
670
|
|
|
‡a
Author's Anakinra delayed skin allergy expressing as both injection site reactions and generalized exanthema
|
|
670
|
|
|
‡a
Author's [Angioedema and anaphylaxis]
|
|
670
|
|
|
‡a
Author's Angiokeratoma induced by injection of etanercept for psoriasis
|
|
670
|
|
|
‡a
Author's Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia.
|
|
670
|
|
|
‡a
Author's Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat
|
|
670
|
|
|
‡a
Author's Anti-CD4 monoclonal antibody therapy in severe psoriasis
|
|
670
|
|
|
‡a
Author's Anti-inflammatory and immune-regulatory mechanisms prevent contact hypersensitivity to Arnica montana L.
|
|
670
|
|
|
‡a
Author's Arterial thrombosis with anti-phospholipid antibodies induced by infliximab
|
|
670
|
|
|
‡a
Author's [Atopic dermatitis is not an allergic disease]
|
|
670
|
|
|
‡a
Author's Autoantibody formation against a 190-kDa antigen of the desmosomal plaque in pemphigus foliaceus
|
|
670
|
|
|
‡a
Author's Autoimmune hepatitis in two psoriasis patients treated with inflixmab
|
|
670
|
|
|
‡a
Author's Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients
|
|
670
|
|
|
‡a
Author's [Basal cell epitheliomatosis of the face in a man who had handled pitch]
|
|
670
|
|
|
‡a
Author's [Biological diagnosis of immediate drug allergy. Comparative study of histamine liberation tests and CD63 expression by flow cytometry
|
|
670
|
|
|
‡a
Author's [Biological diagnosis of immediate drug allergy. Comparative study of histamine liberation tests and CD63 expression by flow cytometry (preliminary results)]
|
|
670
|
|
|
‡a
Author's Blocking T helper 1/T helper 17 pathways has no effect on patch testing
|
|
670
|
|
|
‡a
Author's [Bullous dermatosis in adults. Diagnostic orientation]
|
|
670
|
|
|
‡a
Author's Bullous pemphigoid and cicatricial pemphigoid: immunoblotting detection of involved autoantigens
|
|
670
|
|
|
‡a
Author's [Bullous scleroderma with the histological appearance of lichen sclerosus et atrophicus]
|
|
670
|
|
|
‡a
Author's [Bullous toxic dermatitis due to disulfiram. Apropos of a case]
|
|
670
|
|
|
‡a
Author's CD4 antibody therapy and cyclosporin A differentially affect HLA-DR and ICAM-1 expression in psoriatic skin.
|
|
670
|
|
|
‡a
Author's CD4 antibody therapy in chronic inflammatory dermatological diseases.
|
|
670
|
|
|
‡a
Author's CD4 antibody treatment of severe psoriasis
|
|
670
|
|
|
‡a
Author's CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease.
|
|
670
|
|
|
‡a
Author's CD45R antigen is expressed on eosinophils in paraffin-embedded tissue sections
|
|
670
|
|
|
‡a
Author's CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice.
|
|
670
|
|
|
‡a
Author's CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis
|
|
670
|
|
|
‡a
Author's [Cell adhesion molecules and skin diseases]
|
|
670
|
|
|
‡a
Author's Characterization of the T cell response in allergic contact dermatitis caused by corticosteroids.
|
|
670
|
|
|
‡a
Author's [Chronic inflammatory arthritis and palmoplantar pustulosis]
|
|
670
|
|
|
‡a
Author's Chronic spontaneous urticaria is not an allergic disease
|
|
670
|
|
|
‡a
Author's [Chronic urticaria and corticodependence: corticosteroids have no role in the treatment of urticaria]
|
|
670
|
|
|
‡a
Author's Chronic urticaria and hormones: Is there a link?
|
|
670
|
|
|
‡a
Author's Clonal origin of the mammalian forebrain from widespread oriented mi xing of early regionalized neuroepithelium precursors.
|
|
670
|
|
|
‡a
Author's Comparative histological analysis of drug-induced maculopapular exanthema and DRESS.
|
|
670
|
|
|
‡a
Author's Comparative histology and immunohistochemistry of porcine versus human skin
|
|
670
|
|
|
‡a
Author's Comparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2
|
|
670
|
|
|
‡a
Author's Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus
|
|
670
|
|
|
‡a
Author's Constitutive expression of Ia molecules by murine epithelial cells: a comparison between keratinocytes and enterocytes
|
|
670
|
|
|
‡a
Author's Contact dermatitis I. Pathophysiology of contact sensitivity
|
|
670
|
|
|
‡a
Author's Contact sensitivity in mice: differential effect of vitamin D3 derivative
|
|
670
|
|
|
‡a
Author's Contact sensitivity in mice: differential effect of vitamin D3 derivative (calcipotriol) and corticosteroids
|
|
670
|
|
|
‡a
Author's Contribution of CD4(+ )and CD8(+) T-cells in contact hypersensitivity and allergic contact dermatitis.
|
|
670
|
|
|
‡a
Author's Corticosteroid cross-reactivity: clinical and molecular modelling tools
|
|
670
|
|
|
‡a
Author's Corticosteroids should not be used in urticaria because of the potential risk of steroid dependence and development of severe anti-H1- resistant urticaria
|
|
670
|
|
|
‡a
Author's CpG immunostimulatory sequences enhance contact hypersensitivity responses in mice.
|
|
670
|
|
|
‡a
Author's Culture of dendritic cells from a nonlymphoid organ, the thyroid gland: evidence for TNF Alpha -dependent phenotypic changes of thyroid-derived dendritic cells
|
|
670
|
|
|
‡a
Author's [Cutaneous signs of disseminated gonococcal infections. An update apropos of 2 cases]
|
|
670
|
|
|
‡a
Author's [Cyclosporine and Darier's disease]
|
|
670
|
|
|
‡a
Author's Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity.
|
|
670
|
|
|
‡a
Author's Deciphering Differential Behavior of Immune Responses as the Foundation for Precision Dosing in Allergen Immunotherapy
|
|
670
|
|
|
‡a
Author's Decreased expression of keratinocyte beta1 integrins in chronically sun-exposed skin in vivo.
|
|
670
|
|
|
‡a
Author's Decreased levels of T-cells and cells with suppressor T-cell phenotype as defined by specific monoclonal antibodies in patients with atopic dermatitis
|
|
670
|
|
|
‡a
Author's Depletion of human peripheral blood lymphocytes in CD25+ cells allows for the sensitive in vitro screening of contact allergens
|
|
670
|
|
|
‡a
Author's [Dermo-epidermal junction: current update]
|
|
670
|
|
|
‡a
Author's Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry
|
|
670
|
|
|
‡a
Author's Diagnosis of latent tuberculosis infection
|
|
670
|
|
|
‡a
Author's Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF- Alpha treatment--the tuberculin skin test is useful.
|
|
670
|
|
|
‡a
Author's Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses
|
|
670
|
|
|
‡a
Author's Disseminated porokeratosis transiently healed by cancer chemotherapy
|
|
670
|
|
|
‡a
Author's Dissociation of allergenic and immunogenic functions in contact sensitivity to para-phenylenediamine.
|
|
670
|
|
|
‡a
Author's Diversity of cutaneous bacteria decreases inflammation
|
|
670
|
|
|
‡a
Author's Do epidermal cells produce thymic hormones in vivo? An immunohistochemical study using anti-thymic hormone antibodies
|
|
670
|
|
|
‡a
Author's Do we have to recommend not using oat-containing emollients in children with atopic dermatitis?
|
|
670
|
|
|
‡a
Author's Down-regulation of lymphocyte CD4 antigen expression by administration of anti-CD4 monoclonal antibody
|
|
670
|
|
|
‡a
Author's DRESS is a cause of increased serum procalcitonin level without bacterial infection.
|
|
670
|
|
|
‡a
Author's [Drug hypersensitivity]
|
|
670
|
|
|
‡a
Author's Drug hypersensitivity: definitions and mechanisms
|
|
670
|
|
|
‡a
Author's Drug-induced aphthae
|
|
670
|
|
|
‡a
Author's Drug-induced aseptic meningitis: A possible T-cell-mediated hypersensitivity.
|
|
670
|
|
|
‡a
Author's Drug-induced epidermal necrolysis: Important new piece to end the puzzle
|
|
670
|
|
|
‡a
Author's DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS
|
|
670
|
|
|
‡a
Author's Drug-induced urticaria
|
|
670
|
|
|
‡a
Author's Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): clinco-histopathologic studies of 45 cases.
|
|
670
|
|
|
‡a
Author's Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases.
|
|
670
|
|
|
‡a
Author's Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation
|
|
670
|
|
|
‡a
Author's Early or late expression of Ia antigen on mouse keratinocytes in allergic contact dermatitis?
|
|
670
|
|
|
‡a
Author's Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines.
|
|
670
|
|
|
‡a
Author's Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children
|
|
670
|
|
|
‡a
Author's Editorial
|
|
670
|
|
|
‡a
Author's Effector and regulatory mechanisms in allergic contact dermatitis.
|
|
670
|
|
|
‡a
Author's Effects of local corticosteroids on acute experimental urticaria.
|
|
670
|
|
|
‡a
Author's Encapsulation of hydrophobic allergens into nanoparticles improves the in vitro immunological diagnosis of allergic contact dermatitis.
|
|
670
|
|
|
‡a
Author's [Epicutaneous testing of patients presenting atopic dermatitis: atopy patch tests]
|
|
670
|
|
|
‡a
Author's [Epidemiology and pathophysiology of eczemas]
|
|
670
|
|
|
‡a
Author's Epidermal cell-derived lymphocyte differentiating factor
|
|
670
|
|
|
‡a
Author's Epidermal cell-derived lymphocyte differentiating factor (ELDIF) inhibits in vitro lymphoproliferative responses and interleukin 2 production
|
|
670
|
|
|
‡a
Author's [Epidermal cytokines and cutaneous inflammation]
|
|
670
|
|
|
‡a
Author's Epidermolysis bullosa acquisita in a 3 1/2-year-old girl
|
|
670
|
|
|
‡a
Author's Epidermolysis bullosa simplex generalized severe induces a T helper 17 response and is improved by apremilast treatment
|
|
670
|
|
|
‡a
Author's Epithelial cell heterogeneity in the guinea pig thymus: immunohistochemical characterization of four thymic epithelial subsets defined by monoclonal anti-keratin antibodies.
|
|
670
|
|
|
‡a
Author's Esomeprazole-induced DRESS syndrome. Studies of cross-reactivity among proton-pump inhibitor drugs
|
|
670
|
|
|
‡a
Author's Establishment of nickel-specific T cell lines from patients with allergic contact dermatitis: comparison of different protocols.
|
|
670
|
|
|
‡a
Author's Expression of the Alpha 6 beta 4 integrin in lesional skin differentiates bullous pemphigoid
|
|
670
|
|
|
‡a
Author's Expression of the Alpha 6 beta 4 integrin in lesional skin differentiates bullous pemphigoid (BP) from epidermolysis bullosa acquisita (EBA).
|
|
670
|
|
|
‡a
Author's [Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis]
|
|
670
|
|
|
‡a
Author's [Future of malignant stage I melanoma. Immunology and immunotherapy]
|
|
670
|
|
|
‡a
Author's Glycopeptide-induced cutaneous adverse reaction
|
|
670
|
|
|
‡a
Author's [Gougerot-Sjögren syndrome and IgM monoclonal gammopathy]
|
|
670
|
|
|
‡a
Author's Grade 3 anaphylactic shock after administration of [99mTc]-labeled nanocolloidal albumin (Nanocoll®) for sentinel node scintigraphy
|
|
670
|
|
|
‡a
Author's Heterogeneity of thymic epithelial cell
|
|
670
|
|
|
‡a
Author's Heterogeneity of thymic epithelial cell (TEC) keratins--immunohistochemical and biochemical evidence for a subset of highly differentiated TEC in the mouse
|
|
670
|
|
|
‡a
Author's [Histaminergic angioedema and chronic urticaria]
|
|
670
|
|
|
‡a
Author's [How to understand psoriasis?]
|
|
670
|
|
|
‡a
Author's Human monoclonal autoantibodies specific for the bullous pemphigoid antigen 1
|
|
670
|
|
|
‡a
Author's Human monoclonal autoantibodies specific for the bullous pemphigoid antigen 1 (BPAg 1)
|
|
670
|
|
|
‡a
Author's Human T cell priming assay: depletion of peripheral blood lymphocytes in CD25(+) cells improves the in vitro detection of weak allergen-specific T cells.
|
|
670
|
|
|
‡a
Author's Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid
|
|
670
|
|
|
‡a
Author's IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen
|
|
670
|
|
|
‡a
Author's IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)
|
|
670
|
|
|
‡a
Author's IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid
|
|
670
|
|
|
‡a
Author's IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis
|
|
670
|
|
|
‡a
Author's Immediate hypersensitivity is rarely implicated in drug induced urticaria
|
|
670
|
|
|
‡a
Author's [Immediate reactions to local anesthetics: diagnostic and therapeutic procedures]
|
|
670
|
|
|
‡a
Author's [Immunofluorescence techniques applied to the diagnosis of autoimmune bullous skin diseases of the dermoepidermal junction]
|
|
670
|
|
|
‡a
Author's Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination
|
|
670
|
|
|
‡a
Author's Immunohistopathological study of autoimmune pemphigus. Lack of strictly specific histological and indirect immunofluorescence criteria for paraneoplastic pemphigus
|
|
670
|
|
|
‡a
Author's [Immunointervention in psoriasis. Pathogenic consequences]
|
|
670
|
|
|
‡a
Author's Immunological and non immunological mechanisms in urticaria
|
|
670
|
|
|
‡a
Author's Immunomodulating agents in dermatology
|
|
670
|
|
|
‡a
Author's Immunoprotection by polyethylene glycol in organ preservation solutions is not due to an immunomasking effect
|
|
670
|
|
|
‡a
Author's Immunosuppressive antimetabolites inhibit induction of contact hypersensitivity while lymphoablative drugs also prevent its expression.
|
|
670
|
|
|
‡a
Author's In-situ preferential usage of V Alpha 8 T-cell receptor gene segments in a patient with bullous pemphigoid
|
|
670
|
|
|
‡a
Author's In vitro T cell response to staphylococcal enterotoxin B superantigen in chronic plaque type psoriasis.
|
|
670
|
|
|
‡a
Author's Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
|
|
670
|
|
|
‡a
Author's Inhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergy
|
|
670
|
|
|
‡a
Author's Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation.
|
|
670
|
|
|
‡a
Author's Interferon-gamma production in skin during contact hypersensitivity. No contribution from keratinocytes
|
|
670
|
|
|
‡a
Author's Interleukin-1 beta stimulates fibroblast elastase activity
|
|
670
|
|
|
‡a
Author's [Interleukin-2 immunotherapy and cutaneous manifestations]
|
|
670
|
|
|
‡a
Author's Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. Potential role in fibrosis
|
|
670
|
|
|
‡a
Author's Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents
|
|
670
|
|
|
‡a
Author's Interleukin-6 in normal skin and psoriasis
|
|
670
|
|
|
‡a
Author's Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
|
|
670
|
|
|
‡a
Author's Is there a link between chronic urticaria and atopy?
|
|
670
|
|
|
‡a
Author's [Isolated arthritis of the sternal manubrium and palmo-plantar pustular psoriasis]
|
|
670
|
|
|
‡a
Author's Jean Thivolet.
|
|
670
|
|
|
‡a
Author's Kaposi's sarcoma in a patient with rheumatoid arthritis possible responsibility of captopril in the development of lesions
|
|
670
|
|
|
‡a
Author's Keratinocyte derived soluble factors which influence lymphocyte proliferation
|
|
670
|
|
|
‡a
Author's Keratinocyte-fibroblast interactions: I. Production by the keratinocytes of soluble factors stimulating the proliferation of normal human skin fibroblasts
|
|
670
|
|
|
‡a
Author's Lack of oral tolerance but oral priming for contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice
|
|
670
|
|
|
‡a
Author's Laminaria ochroleuca extract reduces skin inflammation
|
|
670
|
|
|
‡a
Author's Laminins, via heparan sulfate proteoglycans, participate in zebrafish myotome morphogenesis by modulating the pattern of Bmp responsiveness.
|
|
670
|
|
|
‡a
Author's Levomepromazine-induced peripheral edema
|
|
670
|
|
|
‡a
Author's [Lichen planus pemphigoides]
|
|
670
|
|
|
‡a
Author's Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils
|
|
670
|
|
|
‡a
Author's Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens
|
|
670
|
|
|
‡a
Author's [Linear IgA dermatosis induced by penicillin G]
|
|
670
|
|
|
‡a
Author's [Localized pemphigoid after radiotherapy]
|
|
670
|
|
|
‡a
Author's Long-lasting allergic contact dermatitis to methylisothiazolinone misdiagnosed as atopic dermatitis
|
|
670
|
|
|
‡a
Author's Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses
|
|
670
|
|
|
‡a
Author's Major antigenic epitopes of bullous pemphigoid 230 kDa antigen map within the C-terminal end of the protein. Evidence using a 55 kDa recombinant protein.
|
|
670
|
|
|
‡a
Author's Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene
|
|
670
|
|
|
‡a
Author's Measles-Mumps-Rubella vaccination of an egg-allergic child sensitized to gelatin
|
|
670
|
|
|
‡a
Author's Mechanism of measles virus-induced suppression of inflammatory immune responses.
|
|
670
|
|
|
‡a
Author's [Medical treatment of Raynaud's syndrome]
|
|
670
|
|
|
‡a
Author's Methotrexate does not impede the development of contact allergy.
|
|
670
|
|
|
‡a
Author's Methotrexate for the treatment of adult atopic dermatitis
|
|
670
|
|
|
‡a
Author's Methotrexate in atopic eczema. Comments to: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II
|
|
670
|
|
|
‡a
Author's Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial.
|
|
670
|
|
|
‡a
Author's [Muckle-Wells syndrome: a new familial case. Demonstration of abnormalities of lymphocyte subpopulations]
|
|
670
|
|
|
‡a
Author's [Neither skin tests nor challenge tests are sufficient to provide formal diagnosis of drug allergy or sensitisation. A discussion of the article "Two medicines of similar imputability in dermal adverse drug reactions (two cases): the limitations of
|
|
670
|
|
|
‡a
Author's [NSAID urticaria: Similar management to acute urticaria]
|
|
670
|
|
|
‡a
Author's Numeration of T cell subsets in sarcoidosis using monoclonal antibodies: decreased levels of peripheral blood T cells and cells with suppressor T cell phenotype
|
|
670
|
|
|
‡a
Author's Occupational immediate contact allergy to hydrolysed wheat protein after cosmetic exposure
|
|
670
|
|
|
‡a
Author's Optic neuritis associated with tumor necrosis factor-alfa antagonists for the treatment of psoriasis
|
|
670
|
|
|
‡a
Author's Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers
|
|
670
|
|
|
‡a
Author's Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells
|
|
670
|
|
|
‡a
Author's Patch, prick or intradermal tests to detect delayed hypersensitivity to corticosteroids?
|
|
670
|
|
|
‡a
Author's Patch testing in atopic dermatitis patients.
|
|
670
|
|
|
‡a
Author's [Pathogenesis of atopic dermatitis]
|
|
670
|
|
|
‡a
Author's [Pathophysiology of urticaria]
|
|
670
|
|
|
‡a
Author's [Pathophysiology of urticaria and therapeutic approaches]
|
|
670
|
|
|
‡a
Author's Pemphigoid gestationis with autoantibodies exclusively directed to the 230-kDa bullous pemphigoid antigen
|
|
670
|
|
|
‡a
Author's Pemphigoid gestationis with autoantibodies exclusively directed to the 230-kDa bullous pemphigoid antigen (BP230Ag)
|
|
670
|
|
|
‡a
Author's [Pemphigoid mimicking epidermolysis bullosa acquisita]
|
|
670
|
|
|
‡a
Author's [Pemphigus: from clinical observation to molecular biology]
|
|
670
|
|
|
‡a
Author's Peripheral natural killer cells exhibit qualitative and quantitative changes in patients with psoriasis and atopic dermatitis
|
|
670
|
|
|
‡a
Author's Photoageing shows histological features of chronic skin inflammation without clinical and molecular abnormalities
|
|
670
|
|
|
‡a
Author's [Physiopathology of atopic dermatitis]
|
|
670
|
|
|
‡a
Author's [Physiopathology of eczema]
|
|
670
|
|
|
‡a
Author's Pityriasis lichenoides chronica induced by adalimumab therapy for Crohn's disease: report of 2 cases successfully treated with methotrexate
|
|
670
|
|
|
‡a
Author's Porphyria cutanea tarda after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
|
|
670
|
|
|
‡a
Author's [Porphyria cutanea tarda in a patient undergoing bone marrow transplant. Addition of chronic cyt Omega lovirus hepatitis and multiple hepatic aggressions]
|
|
670
|
|
|
‡a
Author's Prevention of aspirin-induced angioedema with an association of leukotriene inhibitors and antihistamines
|
|
670
|
|
|
‡a
Author's Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema.
|
|
670
|
|
|
‡a
Author's Production of a lymphocyte differentiating factor
|
|
670
|
|
|
‡a
Author's Production of a lymphocyte differentiating factor (ELDIF) by cultured human epidermal cells
|
|
670
|
|
|
‡a
Author's [Psoriasis: how the epithelium influences the immune response: keratinocytes, dendritic cells and T lymphocytes]
|
|
670
|
|
|
‡a
Author's Psoriatic arthritis affecting the sternoxiphoid joint
|
|
670
|
|
|
‡a
Author's Psychological Stress Exerts an Adjuvant Effect on Skin Dendritic Cell Functions In Vivo
|
|
670
|
|
|
‡a
Author's Recurrent angioedema: diagnosis strategy and biological aspects
|
|
670
|
|
|
‡a
Author's [Recurrent pyoderma gangrenosum-like ulcers induced by oral anticoagulants]
|
|
670
|
|
|
‡a
Author's Relationship of B cell Fc receptors to T cell recognition of Mls antigen.
|
|
670
|
|
|
‡a
Author's Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon Alpha 2a
|
|
670
|
|
|
‡a
Author's Role of CD4+ T cells and of the CD4 molecule in contact sensitivity
|
|
670
|
|
|
‡a
Author's Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans
|
|
670
|
|
|
‡a
Author's [Sensitisation versus tolerance in contact eczema]
|
|
670
|
|
|
‡a
Author's Sequential histological and immunohistochemical study of the skin of the first human hand allograft
|
|
670
|
|
|
‡a
Author's Serological diagnosis of bullous pemphigoid
|
|
670
|
|
|
‡a
Author's Serological diagnosis of bullous pemphigoid (BP): comparison of the sensitivity of indirect immunofluorescence on salt-split skin to immunoblotting
|
|
670
|
|
|
‡a
Author's Severe hypocalcemia and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome under deferasirox therapy for myelodysplasic syndrome
|
|
670
|
|
|
‡a
Author's Severe immediate hypersensitivity and allergic contact dermatitis caused by hair dyes
|
|
670
|
|
|
‡a
Author's Severe sporotrichoid fishtank granuloma following infliximab therapy for Crohn's disease
|
|
670
|
|
|
‡a
Author's Skin ageing: clinical and histopathologic study of permanent and reducible wrinkles.
|
|
670
|
|
|
‡a
Author's Skin contact irritation conditions the development and severity of allergic contact dermatitis.
|
|
670
|
|
|
‡a
Author's Skin delayed-type hypersensitivity to josamycin.
|
|
670
|
|
|
‡a
Author's Skin exposure to weak and moderate contact allergens induces IFNgamma production by lymph node cells of CD4+ T-cell-depleted mice
|
|
670
|
|
|
‡a
Author's Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions
|
|
670
|
|
|
‡a
Author's Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis.
|
|
670
|
|
|
‡a
Author's Skin tests may induce DRESS relapse.
|
|
670
|
|
|
‡a
Author's SLIT prevents the development of eczema in percutaneous allergen-sensitized mice
|
|
670
|
|
|
‡a
Author's Studies on T-cell subsets in atopic dermatitis: human T-cell subpopulations defined by specific monoclonal antibodies
|
|
670
|
|
|
‡a
Author's [Study of epitopic sites of the major bullous pemphigoid antigen
|
|
670
|
|
|
‡a
Author's [Study of epitopic sites of the major bullous pemphigoid antigen (BPAg1)]
|
|
670
|
|
|
‡a
Author's Suboptimal non-inflammatory concentrations of haptens may elicit a contact sensitivity reaction when used as a mix
|
|
670
|
|
|
‡a
Author's Systemic allergic contact dermatitis to black cumin essential oil expressing as generalized erythema multiforme
|
|
670
|
|
|
‡a
Author's T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays.
|
|
670
|
|
|
‡a
Author's T-cell repertoire analysis in chronic plaque psoriasis suggests an antigen-specific immune response.
|
|
670
|
|
|
‡a
Author's T cell responses to contact allergens.
|
|
670
|
|
|
‡a
Author's T cells in bullous pemphigoid. Presence of activated CD4+ T cells at the basement membrane zone in pre- and peri-bullous skin
|
|
670
|
|
|
‡a
Author's [T lymphocytes in the pathogenesis of chronic inflammatory skin diseases]
|
|
670
|
|
|
‡a
Author's Temporal variations of PM1 major components in an urban street canyon.
|
|
670
|
|
|
‡a
Author's [The desmosome: structure, function and acquired pathology]
|
|
670
|
|
|
‡a
Author's The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skin
|
|
670
|
|
|
‡a
Author's The popliteal lymph node response to streptozotocin is under type 1, MHC class-I restricted, CD8(+) T-cell control
|
|
670
|
|
|
‡a
Author's [The relevance of diagnostic criteria for latent tuberculosis before initiation of TNF- Alpha inhibitors in psoriasis patients]
|
|
670
|
|
|
‡a
Author's The role of dendritic cells in contact hypersensitivity
|
|
670
|
|
|
‡a
Author's [The role of the T-lymphocyte in atopic dermatitis]
|
|
670
|
|
|
‡a
Author's The skin allergenic properties of chemicals may depend on contaminants--evidence from studies on coumarin
|
|
670
|
|
|
‡a
Author's Therapeutic patient education improves knowledge and skills for patients with chronic spontaneous urticaria
|
|
670
|
|
|
‡a
Author's Therapeutic use of TP5
|
|
670
|
|
|
‡a
Author's Therapeutic use of TP5 (thymopoietin 32–36) in sarcoidosis of the skin
|
|
670
|
|
|
‡a
Author's [Thymus hormones in dermatology]
|
|
670
|
|
|
‡a
Author's [TNF Alpha in the physiopathology of psoriasis]
|
|
670
|
|
|
‡a
Author's [Tolerability of oral administration of carboxymethylcellulose in two patients presenting anaphylactic reaction after carboxymethylcellulose injection]
|
|
670
|
|
|
‡a
Author's Tolerance of methotrexate in a daily practice cohort of adults with atopic dermatitis
|
|
670
|
|
|
‡a
Author's Tolerance of oat-based topical products in cereal-sensitized adults with atopic dermatitis.
|
|
670
|
|
|
‡a
Author's Topical ivermectin improves allergic skin inflammation.
|
|
670
|
|
|
‡a
Author's Treatment of chronic spontaneous urticaria: Immunomodulatory approaches
|
|
670
|
|
|
‡a
Author's Treatment with propranolol of 6 patients with idiopathic aquagenic pruritus.
|
|
670
|
|
|
‡a
Author's Tributes to Jean Thivolet
|
|
670
|
|
|
‡a
Author's Tributes to Jean Thivolet (1926-2011).
|
|
670
|
|
|
‡a
Author's Unexpected immediate allergy to amoxicillin
|
|
670
|
|
|
‡a
Author's Urticaria paradoxically aggraved by H1 antihistamines
|
|
670
|
|
|
‡a
Author's Usefulness of basophil activation tests for the diagnosis of IgE-mediated allergy to quinolones
|
|
670
|
|
|
‡a
Author's UV Radiation Induces the Epidermal Recruitment of Dendritic Cells that Compensate for the Depletion of Langerhans Cells in Human Skin.
|
|
670
|
|
|
‡a
Author's [Vaccine-induced urticaria: how to differentiate allergy
|
|
670
|
|
|
‡a
Author's [Vaccine-induced urticaria: how to differentiate allergy (IgE) from pseudoallergy?]
|
|
670
|
|
|
‡a
Author's Vesiculobullous disseminated lupus erythematosus. Apropos of a case
|
|
670
|
|
|
‡a
Author's Vitreoscilla filiformis bacterial extract to improve the efficacy of emollient used in atopic dermatitis symptoms
|
|
670
|
|
|
‡a
Author's WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12
|
|
670
|
|
|
‡a
Author's [Why a "urticaria" group of the French dermatological society?]
|
|
670
|
|
|
‡a
Author's Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate
|
|
670
|
|
|
‡a
Author's সম্পাদকীয়
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NUKAT|n 0102002228
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000116586999
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/64144213
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|035185201
|
|
909
|
|
|
‡a
(orcid) 000000034204803x
‡9
1
|
|
912
|
|
|
‡a
editorial
‡A
Editorial
‡9
1
|
|
912
|
|
|
‡a
7drughypersensitivitymeetingpart2
‡A
7th Drug hypersensitivity meeting: part two.
‡9
1
|
|
912
|
|
|
‡a
সমপদকয
‡A
সম্পাদকীয়
‡9
1
|
|
919
|
|
|
‡a
encapsulationofhydrophobicallergensintonanoparticlesimprovestheinvitroimmunologicaldiagnosisofallergiccontactdermatitis
‡A
Encapsulation of hydrophobic allergens into nanoparticles improves the in vitro immunological diagnosis of allergic contact dermatitis.
‡9
1
|
|
919
|
|
|
‡a
effectorandregulatorymechanismsinallergiccontactdermatitis
‡A
Effector and regulatory mechanisms in allergic contact dermatitis.
‡9
1
|
|
919
|
|
|
‡a
echographicmeasurementofskinthicknessinsitessuitableforintradermalvaccineinjectionininfantsandchildren
‡A
Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children
‡9
1
|
|
919
|
|
|
‡a
casefordiagnosissuperficialpemphiguspresentingasgiantkeratoticlesions
‡A
[A case for diagnosis: superficial pemphigus presenting as giant keratotic lesions]
‡9
1
|
|
919
|
|
|
‡a
perspectiveontheinterplayofultravioletradiationskinmicrobiomeandskinresidentmemorytcrαβ+cells
‡A
A Perspective on the Interplay of Ultraviolet-Radiation, Skin Microbiome and Skin Resident Memory TCRαβ+ Cells.
‡9
1
|
|
919
|
|
|
‡a
activationofflucloxacillinspecificcd8+tcellswiththepotentialtopromotehepatocytecytotoxicityinamousemodel
‡A
Activation of Flucloxacillin-Specific CD8+ T-Cells With the Potential to Promote Hepatocyte Cytotoxicity in a Mouse Model.
‡9
1
|
|
919
|
|
|
‡a
adhesionmoleculestheirpotentialimplicationfordermatology
‡A
[Adhesion molecules: their potential implication for dermatology]
‡9
1
|
|
919
|
|
|
‡a
allergenpenetrationthroughtheskin
‡A
Allergen penetration through the skin.
‡9
1
|
|
919
|
|
|
‡a
allergiccontactdermatitis
‡A
Allergic contact dermatitis
‡9
1
|
|
919
|
|
|
‡a
allergiccontactdermatitishowtoreinducetolerance
‡A
[Allergic contact dermatitis: how to re-induce tolerance?]
‡9
1
|
|
919
|
|
|
‡a
allergicdelayeddrughypersensitivityismorefrequentlydiagnosedindrugreactioneosinophiliaandsystemicsymptomsdresssyndromethaninexanthemainducedbybetalactamantibiotics
‡A
Allergic delayed drug hypersensitivity is more frequently diagnosed in drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome than in exanthema induced by beta-lactam antibiotics
‡9
1
|
|
919
|
|
|
‡a
allergicreactiontomethylprednisolone
‡A
Allergic reaction to methylprednisolone
‡9
1
|
|
919
|
|
|
‡a
alopeciaareatauniversalisduringtreatmentofrheumatoidarthritiswithantitnf Alpha antibodyadalimumab
‡A
Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF- Alpha antibody (adalimumab)
‡9
1
|
|
919
|
|
|
‡a
Alpha interferontreatmentinatopicdermatitis
‡A
Alpha interferon treatment in atopic dermatitis
‡9
1
|
|
919
|
|
|
‡a
ambroxolinducedtoxicoderma
‡A
Ambroxol-induced toxicoderma
‡9
1
|
|
919
|
|
|
‡a
amikacininduceddrugreactionwitheosinophiliaandsystemicsymptomssyndromedelayedskintestandelispotassayresultsallowtheidentificationoftheculpritdrug
‡A
Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug
‡9
1
|
|
919
|
|
|
‡a
anakinradelayedskinallergyexpressingasbothinjectionsitereactionsandgeneralizedexanthema
‡A
Anakinra delayed skin allergy expressing as both injection site reactions and generalized exanthema
‡9
1
|
|
919
|
|
|
‡a
angioedemaandanaphylaxis
‡A
[Angioedema and anaphylaxis]
‡9
1
|
|
919
|
|
|
‡a
angiokeratomainducedbyinjectionofetanerceptforpsoriasis
‡A
Angiokeratoma induced by injection of etanercept for psoriasis
‡9
1
|
|
919
|
|
|
‡a
anophelesmosquitobitesactivatecutaneousmastcellsleadingtoalocalinflammatoryresponseandlymphnodehyperplasia
‡A
Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia.
‡9
1
|
|
919
|
|
|
‡a
antagonisticeffectofinterferongammaontatinducedtransactivationofhivlongterminalrepeat
‡A
Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat
‡9
1
|
|
919
|
|
|
‡a
anticd4monoclonalantibodytherapyinseverepsoriasis
‡A
Anti-CD4 monoclonal antibody therapy in severe psoriasis
‡9
1
|
|
919
|
|
|
‡a
antiinflammatoryandimmuneregulatorymechanismspreventcontacthypersensitivitytoarnicamontana50
‡A
Anti-inflammatory and immune-regulatory mechanisms prevent contact hypersensitivity to Arnica montana L.
‡9
1
|
|
919
|
|
|
‡a
arterialthrombosiswithantiphospholipidantibodiesinducedbyinfliximab
‡A
Arterial thrombosis with anti-phospholipid antibodies induced by infliximab
‡9
1
|
|
919
|
|
|
‡a
atopicdermatitisisnotanallergicdisease
‡A
[Atopic dermatitis is not an allergic disease]
‡9
1
|
|
919
|
|
|
‡a
autoantibodyformationagainsta190kdaantigenofthedesmosomalplaqueinpemphigusfoliaceus
‡A
Autoantibody formation against a 190-kDa antigen of the desmosomal plaque in pemphigus foliaceus
‡9
1
|
|
919
|
|
|
‡a
autoimmunehepatitisin2psoriasispatientstreatedwithinflixmab
‡A
Autoimmune hepatitis in two psoriasis patients treated with inflixmab
‡9
1
|
|
919
|
|
|
‡a
automaticdepletionwithspectraoptiaallowsasafe16reductionofredbloodcellpackconsumptioninexchangedsicklecellanemiapatients
‡A
Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients
‡9
1
|
|
919
|
|
|
‡a
basalcellepitheliomatosisofthefaceinamanwhohadhandledpitch
‡A
[Basal cell epitheliomatosis of the face in a man who had handled pitch]
‡9
1
|
|
919
|
|
|
‡a
biologicaldiagnosisofimmediatedrugallergycomparativestudyofhistamineliberationtestsandcd63expressionbyflowcytometry
‡A
[Biological diagnosis of immediate drug allergy. Comparative study of histamine liberation tests and CD63 expression by flow cytometry
‡9
1
|
|
919
|
|
|
‡a
biologicaldiagnosisofimmediatedrugallergycomparativestudyofhistamineliberationtestsandcd63expressionbyflowcytometrypreliminaryresults
‡A
[Biological diagnosis of immediate drug allergy. Comparative study of histamine liberation tests and CD63 expression by flow cytometry (preliminary results)]
‡9
1
|
|
919
|
|
|
‡a
blockingthelper1thelper17pathwayshasnoeffectonpatchtesting
‡A
Blocking T helper 1/T helper 17 pathways has no effect on patch testing
‡9
1
|
|
919
|
|
|
‡a
bullousdermatosisinadultsdiagnosticorientation
‡A
[Bullous dermatosis in adults. Diagnostic orientation]
‡9
1
|
|
919
|
|
|
‡a
bullouspemphigoidandcicatricialpemphigoidimmunoblottingdetectionofinvolvedautoantigens
‡A
Bullous pemphigoid and cicatricial pemphigoid: immunoblotting detection of involved autoantigens
‡9
1
|
|
919
|
|
|
‡a
bulloussclerodermawiththehistologicalappearanceoflichensclerosusetatrophicus
‡A
[Bullous scleroderma with the histological appearance of lichen sclerosus et atrophicus]
‡9
1
|
|
919
|
|
|
‡a
bulloustoxicdermatitisduetodisulfiramaproposofacase
‡A
[Bullous toxic dermatitis due to disulfiram. Apropos of a case]
‡9
1
|
|
919
|
|
|
‡a
effectsoflocalcorticosteroidsonacuteexperimentalurticaria
‡A
Effects of local corticosteroids on acute experimental urticaria.
‡9
1
|
|
919
|
|
|
‡a
cd4antibodytherapyandcyclosporinadifferentiallyaffecthladrandicam1expressioninpsoriaticskin
‡A
CD4 antibody therapy and cyclosporin A differentially affect HLA-DR and ICAM-1 expression in psoriatic skin.
‡9
1
|
|
919
|
|
|
‡a
cd4antibodytherapyinchronicinflammatorydermatologicaldiseases
‡A
CD4 antibody therapy in chronic inflammatory dermatological diseases.
‡9
1
|
|
919
|
|
|
‡a
cd4antibodytreatmentofseverepsoriasis
‡A
CD4 antibody treatment of severe psoriasis
‡9
1
|
|
919
|
|
|
‡a
cd4+tcellspreventskinautoimmunityduringchronicautologousgraftversushostdisease
‡A
CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease.
‡9
1
|
|
919
|
|
|
‡a
cd45rantigenisexpressedoneosinophilsinparaffinembeddedtissuesections
‡A
CD45R antigen is expressed on eosinophils in paraffin-embedded tissue sections
‡9
1
|
|
919
|
|
|
‡a
cd8+tcellsareeffectorcellsofcontactdermatitistocommonskinallergensinmice
‡A
CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice.
‡9
1
|
|
919
|
|
|
‡a
cd8+tcellsarerecruitedearlytoallergenexposuresitesinatopypatchtestreactionsinhumanatopicdermatitis
‡A
CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis
‡9
1
|
|
919
|
|
|
‡a
celladhesionmoleculesandskindiseases
‡A
[Cell adhesion molecules and skin diseases]
‡9
1
|
|
919
|
|
|
‡a
characterizationofthetcellresponseinallergiccontactdermatitiscausedbycorticosteroids
‡A
Characterization of the T cell response in allergic contact dermatitis caused by corticosteroids.
‡9
1
|
|
919
|
|
|
‡a
chronicinflammatoryarthritisandpalmoplantarpustulosis
‡A
[Chronic inflammatory arthritis and palmoplantar pustulosis]
‡9
1
|
|
919
|
|
|
‡a
chronicspontaneousurticariaisnotanallergicdisease
‡A
Chronic spontaneous urticaria is not an allergic disease
‡9
1
|
|
919
|
|
|
‡a
chronicurticariaandcorticodependencecorticosteroidshavenoroleinthetreatmentofurticaria
‡A
[Chronic urticaria and corticodependence: corticosteroids have no role in the treatment of urticaria]
‡9
1
|
|
919
|
|
|
‡a
chronicurticariaandhormonesistherealink
‡A
Chronic urticaria and hormones: Is there a link?
‡9
1
|
|
919
|
|
|
‡a
clonaloriginofthemammalianforebrainfromwidespreadorientedmi xing ofearlyregionalizedneuroepitheliumprecursors
‡A
Clonal origin of the mammalian forebrain from widespread oriented mi xing of early regionalized neuroepithelium precursors.
‡9
1
|
|
919
|
|
|
‡a
comparativehistologicalanalysisofdruginducedmaculopapularexanthemaanddress
‡A
Comparative histological analysis of drug-induced maculopapular exanthema and DRESS.
‡9
1
|
|
919
|
|
|
‡a
comparativehistologyandimmunohistochemistryofporcineversushumanskin
‡A
Comparative histology and immunohistochemistry of porcine versus human skin
‡9
1
|
|
919
|
|
|
‡a
comparativesensitivityofindirectimmunofluorescencetoimmunoblotassayforthedetectionofcirculatingantibodiestobullouspemphigoidantigens1and2
‡A
Comparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2
‡9
1
|
|
919
|
|
|
‡a
comparativestudyofindirectimmunofluorescenceandimmunoblottingforthediagnosisofautoimmunepemphigus
‡A
Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus
‡9
1
|
|
919
|
|
|
‡a
constitutiveexpressionofiamoleculesbymurineepithelialcellsacomparisonbetweenkeratinocytesandenterocytes
‡A
Constitutive expression of Ia molecules by murine epithelial cells: a comparison between keratinocytes and enterocytes
‡9
1
|
|
919
|
|
|
‡a
contactdermatitis1pathophysiologyofcontactsensitivity
‡A
Contact dermatitis I. Pathophysiology of contact sensitivity
‡9
1
|
|
919
|
|
|
‡a
contactsensitivityinmicedifferentialeffectofvitamind3derivative
‡A
Contact sensitivity in mice: differential effect of vitamin D3 derivative
‡9
1
|
|
919
|
|
|
‡a
contactsensitivityinmicedifferentialeffectofvitamind3derivativecalcipotriolandcorticosteroids
‡A
Contact sensitivity in mice: differential effect of vitamin D3 derivative (calcipotriol) and corticosteroids
‡9
1
|
|
919
|
|
|
‡a
contributionofcd4+andcd8+tcellsincontacthypersensitivityandallergiccontactdermatitis
‡A
Contribution of CD4(+ )and CD8(+) T-cells in contact hypersensitivity and allergic contact dermatitis.
‡9
1
|
|
919
|
|
|
‡a
corticosteroidcrossreactivityclinicalandmolecularmodellingtools
‡A
Corticosteroid cross-reactivity: clinical and molecular modelling tools
‡9
1
|
|
919
|
|
|
‡a
corticosteroidsshouldnotbeusedinurticariabecauseofthepotentialriskofsteroiddependenceanddevelopmentofsevereantih1resistanturticaria
‡A
Corticosteroids should not be used in urticaria because of the potential risk of steroid dependence and development of severe anti-H1- resistant urticaria
‡9
1
|
|
919
|
|
|
‡a
cpgimmunostimulatorysequencesenhancecontacthypersensitivityresponsesinmice
‡A
CpG immunostimulatory sequences enhance contact hypersensitivity responses in mice.
‡9
1
|
|
919
|
|
|
‡a
cultureofdendriticcellsfromanonlymphoidorganthethyroidglandevidencefortnf Alpha dependentphenotypicchangesofthyroidderiveddendriticcells
‡A
Culture of dendritic cells from a nonlymphoid organ, the thyroid gland: evidence for TNF Alpha -dependent phenotypic changes of thyroid-derived dendritic cells
‡9
1
|
|
919
|
|
|
‡a
cutaneoussignsofdisseminatedgonococcalinfectionsanupdateaproposof2cases
‡A
[Cutaneous signs of disseminated gonococcal infections. An update apropos of 2 cases]
‡9
1
|
|
919
|
|
|
‡a
cyclosporineanddariersdisease
‡A
[Cyclosporine and Darier's disease]
‡9
1
|
|
919
|
|
|
‡a
cytotoxicityismandatoryforcd8+tcellmediatedcontacthypersensitivity
‡A
Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity.
‡9
1
|
|
919
|
|
|
‡a
decipheringdifferentialbehaviorofimmuneresponsesasthefoundationforprecisiondosinginallergenimmunotherapy
‡A
Deciphering Differential Behavior of Immune Responses as the Foundation for Precision Dosing in Allergen Immunotherapy
‡9
1
|
|
919
|
|
|
‡a
decreasedexpressionofkeratinocytebeta1integrinsinchronicallysunexposedskininvivo
‡A
Decreased expression of keratinocyte beta1 integrins in chronically sun-exposed skin in vivo.
‡9
1
|
|
919
|
|
|
‡a
decreasedlevelsoftcellsandcellswithsuppressortcellphenotypeasdefinedbyspecificmonoclonalantibodiesinpatientswithatopicdermatitis
‡A
Decreased levels of T-cells and cells with suppressor T-cell phenotype as defined by specific monoclonal antibodies in patients with atopic dermatitis
‡9
1
|
|
919
|
|
|
‡a
depletionofhumanperipheralbloodlymphocytesincd25+cellsallowsforthesensitiveinvitroscreeningofcontactallergens
‡A
Depletion of human peripheral blood lymphocytes in CD25+ cells allows for the sensitive in vitro screening of contact allergens
‡9
1
|
|
919
|
|
|
‡a
dermoepidermaljunctioncurrentupdate
‡A
[Dermo-epidermal junction: current update]
‡9
1
|
|
919
|
|
|
‡a
descriptionandoutcomeofacohortof8patientswithwhimsyndromefromthefrenchseverechronicneutropeniaregistry
‡A
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry
‡9
1
|
|
919
|
|
|
‡a
diagnosisoflatenttuberculosisinfection
‡A
Diagnosis of latent tuberculosis infection
‡9
1
|
|
919
|
|
|
‡a
diagnosisoflatenttuberculosisinfectionltbibeforeantitnf Alpha treatmentthetuberculinskintestisuseful
‡A
Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF- Alpha treatment--the tuberculin skin test is useful.
‡9
1
|
|
919
|
|
|
‡a
diagnosticvalueofindirectimmunofluorescenceonsodiumchloridesplitskinindifferentialdiagnosisofsubepidermalautoimmunebullousdermatoses
‡A
Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses
‡9
1
|
|
919
|
|
|
‡a
disseminatedporokeratosistransientlyhealedbycancerchemotherapy
‡A
Disseminated porokeratosis transiently healed by cancer chemotherapy
‡9
1
|
|
919
|
|
|
‡a
dissociationofallergenicandimmunogenicfunctionsincontactsensitivitytoparaphenylenediamine
‡A
Dissociation of allergenic and immunogenic functions in contact sensitivity to para-phenylenediamine.
‡9
1
|
|
919
|
|
|
‡a
diversityofcutaneousbacteriadecreasesinflammation
‡A
Diversity of cutaneous bacteria decreases inflammation
‡9
1
|
|
919
|
|
|
‡a
doepidermalcellsproducethymichormonesinvivoanimmunohistochemicalstudyusingantithymichormoneantibodies
‡A
Do epidermal cells produce thymic hormones in vivo? An immunohistochemical study using anti-thymic hormone antibodies
‡9
1
|
|
919
|
|
|
‡a
dowehavetorecommendnotusingoatcontainingemollientsinchildrenwithatopicdermatitis
‡A
Do we have to recommend not using oat-containing emollients in children with atopic dermatitis?
‡9
1
|
|
919
|
|
|
‡a
downregulationoflymphocytecd4antigenexpressionbyadministrationofanticd4monoclonalantibody
‡A
Down-regulation of lymphocyte CD4 antigen expression by administration of anti-CD4 monoclonal antibody
‡9
1
|
|
919
|
|
|
‡a
dressisacauseofincreasedserumprocalcitoninlevelwithoutbacterialinfection
‡A
DRESS is a cause of increased serum procalcitonin level without bacterial infection.
‡9
1
|
|
919
|
|
|
‡a
drughypersensitivity
‡A
[Drug hypersensitivity]
‡9
1
|
|
919
|
|
|
‡a
drughypersensitivitydefinitionsandmechanisms
‡A
Drug hypersensitivity: definitions and mechanisms
‡9
1
|
|
919
|
|
|
‡a
druginducedaphthae
‡A
Drug-induced aphthae
‡9
1
|
|
919
|
|
|
‡a
druginducedasepticmeningitisapossibletcellmediatedhypersensitivity
‡A
Drug-induced aseptic meningitis: A possible T-cell-mediated hypersensitivity.
‡9
1
|
|
919
|
|
|
‡a
druginducedepidermalnecrolysisimportantnewpiecetoendthepuzzle
‡A
Drug-induced epidermal necrolysis: Important new piece to end the puzzle
‡9
1
|
|
919
|
|
|
‡a
druginducedexanthemaandseverecutaneousdrugreactions
‡A
DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS
‡9
1
|
|
919
|
|
|
‡a
druginducedurticaria
‡A
Drug-induced urticaria
‡9
1
|
|
919
|
|
|
‡a
drugreactionwitheosinophiliaandsystemicsymptomsdressclincohistopathologicstudiesof45cases
‡A
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): clinco-histopathologic studies of 45 cases.
‡9
1
|
|
919
|
|
|
‡a
drugreactionwitheosinophiliaandsystemicsymptomsdressclinicopathologicalstudyof45cases
‡A
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases.
‡9
1
|
|
919
|
|
|
‡a
dualroleofdendriticcellsintheinductionanddownregulationofantigenspecificcutaneousinflammation
‡A
Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation
‡9
1
|
|
919
|
|
|
‡a
earlyorlateexpressionofiaantigenonmousekeratinocytesinallergiccontactdermatitis
‡A
Early or late expression of Ia antigen on mouse keratinocytes in allergic contact dermatitis?
‡9
1
|
|
919
|
|
|
‡a
echographicmeasurementofskinthicknessinadultsbyhighfrequencyultrasoundtoassesstheappropriatemicroneedlelengthforintradermaldeliveryofvaccines
‡A
Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines.
‡9
1
|
|
919
|
|
|
‡a
xolairinducedrecurrentanaphylaxisthroughsensitizationtotheexcipientpolysorbate
‡A
Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate
‡9
1
|
|
919
|
|
|
‡a
whyaurticariagroupofthefrenchdermatologicalsociety
‡A
[Why a "urticaria" group of the French dermatological society?]
‡9
1
|
|
919
|
|
|
‡a
whimsyndromeswithdifferentgeneticanomaliesareaccountedforbyimpairedcxcr4desensitizationtocxcl12
‡A
WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12
‡9
1
|
|
919
|
|
|
‡a
vitreoscillafiliformisbacterialextracttoimprovetheefficacyofemollientusedinatopicdermatitissymptoms
‡A
Vitreoscilla filiformis bacterial extract to improve the efficacy of emollient used in atopic dermatitis symptoms
‡9
1
|
|
919
|
|
|
‡a
vesiculobullousdisseminatedlupuserythematosusaproposofacase
‡A
Vesiculobullous disseminated lupus erythematosus. Apropos of a case
‡9
1
|
|
919
|
|
|
‡a
vaccineinducedurticariahowtodifferentiateallergyigefrompseudoallergy
‡A
[Vaccine-induced urticaria: how to differentiate allergy (IgE) from pseudoallergy?]
‡9
1
|
|
919
|
|
|
‡a
vaccineinducedurticariahowtodifferentiateallergy
‡A
[Vaccine-induced urticaria: how to differentiate allergy
‡9
1
|
|
919
|
|
|
‡a
uvradiationinducestheepidermalrecruitmentofdendriticcellsthatcompensateforthedepletionoflangerhanscellsinhumanskin
‡A
UV Radiation Induces the Epidermal Recruitment of Dendritic Cells that Compensate for the Depletion of Langerhans Cells in Human Skin.
‡9
1
|
|
919
|
|
|
‡a
usefulnessofbasophilactivationtestsforthediagnosisofigemediatedallergytoquinolones
‡A
Usefulness of basophil activation tests for the diagnosis of IgE-mediated allergy to quinolones
‡9
1
|
|
919
|
|
|
‡a
urticariaparadoxicallyaggravedbyh1antihistamines
‡A
Urticaria paradoxically aggraved by H1 antihistamines
‡9
1
|
|
919
|
|
|
‡a
unexpectedimmediateallergytoamoxicillin
‡A
Unexpected immediate allergy to amoxicillin
‡9
1
|
|
919
|
|
|
‡a
tributestojeanthivolet1926
‡A
Tributes to Jean Thivolet (1926-2011).
‡9
1
|
|
919
|
|
|
‡a
tributestojeanthivolet
‡A
Tributes to Jean Thivolet
‡9
1
|
|
919
|
|
|
‡a
treatmentwithpropranololof6patientswithidiopathicaquagenicpruritus
‡A
Treatment with propranolol of 6 patients with idiopathic aquagenic pruritus.
‡9
1
|
|
919
|
|
|
‡a
treatmentofchronicspontaneousurticariaimmunomodulatoryapproaches
‡A
Treatment of chronic spontaneous urticaria: Immunomodulatory approaches
‡9
1
|
|
919
|
|
|
‡a
topicalivermectinimprovesallergicskininflammation
‡A
Topical ivermectin improves allergic skin inflammation.
‡9
1
|
|
919
|
|
|
‡a
toleranceofoatbasedtopicalproductsincerealsensitizedadultswithatopicdermatitis
‡A
Tolerance of oat-based topical products in cereal-sensitized adults with atopic dermatitis.
‡9
1
|
|
919
|
|
|
‡a
toleranceofmethotrexateinadailypracticecohortofadultswithatopicdermatitis
‡A
Tolerance of methotrexate in a daily practice cohort of adults with atopic dermatitis
‡9
1
|
|
919
|
|
|
‡a
tolerabilityoforaladministrationofcarboxymethylcellulosein2patientspresentinganaphylacticreactionaftercarboxymethylcelluloseinjection
‡A
[Tolerability of oral administration of carboxymethylcellulose in two patients presenting anaphylactic reaction after carboxymethylcellulose injection]
‡9
1
|
|
919
|
|
|
‡a
tnf Alpha inthephysiopathologyofpsoriasis
‡A
[TNF Alpha in the physiopathology of psoriasis]
‡9
1
|
|
919
|
|
|
‡a
thymushormonesindermatology
‡A
[Thymus hormones in dermatology]
‡9
1
|
|
919
|
|
|
‡a
therapeuticuseoftp5thymopoietin3236insarcoidosisoftheskin
‡A
Therapeutic use of TP5 (thymopoietin 32–36) in sarcoidosis of the skin
‡9
1
|
|
919
|
|
|
‡a
therapeuticuseoftp5
‡A
Therapeutic use of TP5
‡9
1
|
|
919
|
|
|
‡a
therapeuticpatienteducationimprovesknowledgeandskillsforpatientswithchronicspontaneousurticaria
‡A
Therapeutic patient education improves knowledge and skills for patients with chronic spontaneous urticaria
‡9
1
|
|
919
|
|
|
‡a
skinallergenicpropertiesofchemicalsmaydependoncontaminantsevidencefromstudiesoncoumarin
‡A
The skin allergenic properties of chemicals may depend on contaminants--evidence from studies on coumarin
‡9
1
|
|
919
|
|
|
‡a
roleofthetlymphocyteinatopicdermatitis
‡A
[The role of the T-lymphocyte in atopic dermatitis]
‡9
1
|
|
919
|
|
|
‡a
roleofdendriticcellsincontacthypersensitivity
‡A
The role of dendritic cells in contact hypersensitivity
‡9
1
|
|
919
|
|
|
‡a
relevanceofdiagnosticcriteriaforlatenttuberculosisbeforeinitiationoftnf Alpha inhibitorsinpsoriasispatients
‡A
[The relevance of diagnostic criteria for latent tuberculosis before initiation of TNF- Alpha inhibitors in psoriasis patients]
‡9
1
|
|
919
|
|
|
‡a
popliteallymphnoderesponsetostreptozotocinisundertype1mhcclass1restrictedcd8+tcellcontrol
‡A
The popliteal lymph node response to streptozotocin is under type 1, MHC class-I restricted, CD8(+) T-cell control
‡9
1
|
|
919
|
|
|
‡a
effectofanticd4monoclonalantibodytreatmentonimmunopathologicalchangesinpsoriaticskin
‡A
The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skin
‡9
1
|
|
919
|
|
|
‡a
desmosomestructurefunctionandacquiredpathology
‡A
[The desmosome: structure, function and acquired pathology]
‡9
1
|
|
919
|
|
|
‡a
temporalvariationsofpm1majorcomponentsinanurbanstreetcanyon
‡A
Temporal variations of PM1 major components in an urban street canyon.
‡9
1
|
|
919
|
|
|
‡a
tlymphocytesinthepathogenesisofchronicinflammatoryskindiseases
‡A
[T lymphocytes in the pathogenesis of chronic inflammatory skin diseases]
‡9
1
|
|
919
|
|
|
‡a
tcellsinbullouspemphigoidpresenceofactivatedcd4+tcellsatthebasementmembranezoneinpreandperibullousskin
‡A
T cells in bullous pemphigoid. Presence of activated CD4+ T cells at the basement membrane zone in pre- and peri-bullous skin
‡9
1
|
|
919
|
|
|
‡a
tcellresponsestocontactallergens
‡A
T cell responses to contact allergens.
‡9
1
|
|
919
|
|
|
‡a
tcellrepertoireanalysisinchronicplaquepsoriasissuggestsanantigenspecificimmuneresponse
‡A
T-cell repertoire analysis in chronic plaque psoriasis suggests an antigen-specific immune response.
‡9
1
|
|
919
|
|
|
‡a
tcellrecognitionofchemicalsproteinallergensanddrugstowardsthedevelopmentofinvitroassays
‡A
T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays.
‡9
1
|
|
919
|
|
|
‡a
systemicallergiccontactdermatitistoblackcuminessentialoilexpressingasgeneralizederythemamultiforme
‡A
Systemic allergic contact dermatitis to black cumin essential oil expressing as generalized erythema multiforme
‡9
1
|
|
919
|
|
|
‡a
suboptimalnoninflammatoryconcentrationsofhaptensmayelicitacontactsensitivityreactionwhenusedasa1009
‡A
Suboptimal non-inflammatory concentrations of haptens may elicit a contact sensitivity reaction when used as a mix
‡9
1
|
|
919
|
|
|
‡a
studyofepitopicsitesofthemajorbullouspemphigoidantigenbpag1
‡A
[Study of epitopic sites of the major bullous pemphigoid antigen (BPAg1)]
‡9
1
|
|
919
|
|
|
‡a
studyofepitopicsitesofthemajorbullouspemphigoidantigen
‡A
[Study of epitopic sites of the major bullous pemphigoid antigen
‡9
1
|
|
919
|
|
|
‡a
studiesontcellsubsetsinatopicdermatitishumantcellsubpopulationsdefinedbyspecificmonoclonalantibodies
‡A
Studies on T-cell subsets in atopic dermatitis: human T-cell subpopulations defined by specific monoclonal antibodies
‡9
1
|
|
919
|
|
|
‡a
slitpreventsthedevelopmentofeczemainpercutaneousallergensensitizedmice
‡A
SLIT prevents the development of eczema in percutaneous allergen-sensitized mice
‡9
1
|
|
919
|
|
|
‡a
skintestsmayinducedressrelapse
‡A
Skin tests may induce DRESS relapse.
‡9
1
|
|
919
|
|
|
‡a
skininflammationduringcontacthypersensitivityismediatedbyearlyrecruitmentofcd8+tcytotoxic1cellsinducingkeratinocyteapoptosis
‡A
Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis.
‡9
1
|
|
919
|
|
|
‡a
skininfiltratingcd8+tcellsinitiateatopicdermatitislesions
‡A
Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions
‡9
1
|
|
919
|
|
|
‡a
skinexposuretoweakandmoderatecontactallergensinducesifngammaproductionbylymphnodecellsofcd4+tcelldepletedmice
‡A
Skin exposure to weak and moderate contact allergens induces IFNgamma production by lymph node cells of CD4+ T-cell-depleted mice
‡9
1
|
|
919
|
|
|
‡a
skindelayedtypehypersensitivitytojosamycin
‡A
Skin delayed-type hypersensitivity to josamycin.
‡9
1
|
|
919
|
|
|
‡a
skincontactirritationconditionsthedevelopmentandseverityofallergiccontactdermatitis
‡A
Skin contact irritation conditions the development and severity of allergic contact dermatitis.
‡9
1
|
|
919
|
|
|
‡a
skinageingclinicalandhistopathologicstudyofpermanentandreduciblewrinkles
‡A
Skin ageing: clinical and histopathologic study of permanent and reducible wrinkles.
‡9
1
|
|
919
|
|
|
‡a
severesporotrichoidfishtankgranulomafollowinginfliximabtherapyforcrohnsdisease
‡A
Severe sporotrichoid fishtank granuloma following infliximab therapy for Crohn's disease
‡9
1
|
|
919
|
|
|
‡a
severeimmediatehypersensitivityandallergiccontactdermatitiscausedbyhairdyes
‡A
Severe immediate hypersensitivity and allergic contact dermatitis caused by hair dyes
‡9
1
|
|
919
|
|
|
‡a
severehypocalcemiaanddrugreactionwitheosinophiliaandsystemicsymptomsdresssyndromeunderdeferasiroxtherapyformyelodysplasicsyndrome
‡A
Severe hypocalcemia and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome under deferasirox therapy for myelodysplasic syndrome
‡9
1
|
|
919
|
|
|
‡a
serologicaldiagnosisofbullouspemphigoidbpcomparisonofthesensitivityofindirectimmunofluorescenceonsaltsplitskintoimmunoblotting
‡A
Serological diagnosis of bullous pemphigoid (BP): comparison of the sensitivity of indirect immunofluorescence on salt-split skin to immunoblotting
‡9
1
|
|
919
|
|
|
‡a
serologicaldiagnosisofbullouspemphigoid
‡A
Serological diagnosis of bullous pemphigoid
‡9
1
|
|
919
|
|
|
‡a
sequentialhistologicalandimmunohistochemicalstudyoftheskinofthe1humanhandallograft
‡A
Sequential histological and immunohistochemical study of the skin of the first human hand allograft
‡9
1
|
|
919
|
|
|
‡a
sensitisationversustoleranceincontacteczema
‡A
[Sensitisation versus tolerance in contact eczema]
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoftranscutaneousvaccinationusingapatchwiththeliveattenuatedmeaslesvaccineinhumans
‡A
Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans
‡9
1
|
|
919
|
|
|
‡a
roleofcd4+tcellsandofthecd4moleculeincontactsensitivity
‡A
Role of CD4+ T cells and of the CD4 molecule in contact sensitivity
‡9
1
|
|
919
|
|
|
‡a
responseofdiscoidandsubacutecutaneouslupuserythematosustorecombinantinterferon Alpha 2a
‡A
Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon Alpha 2a
‡9
1
|
|
919
|
|
|
‡a
relationshipofbcellfcreceptorstotcellrecognitionofmlsantigen
‡A
Relationship of B cell Fc receptors to T cell recognition of Mls antigen.
‡9
1
|
|
919
|
|
|
‡a
recurrentpyodermagangrenosumlikeulcersinducedbyoralanticoagulants
‡A
[Recurrent pyoderma gangrenosum-like ulcers induced by oral anticoagulants]
‡9
1
|
|
919
|
|
|
‡a
recurrentangioedemadiagnosisstrategyandbiologicalaspects
‡A
Recurrent angioedema: diagnosis strategy and biological aspects
‡9
1
|
|
919
|
|
|
‡a
psychologicalstressexertsanadjuvanteffectonskindendriticcellfunctionsinvivo
‡A
Psychological Stress Exerts an Adjuvant Effect on Skin Dendritic Cell Functions In Vivo
‡9
1
|
|
919
|
|
|
‡a
psoriaticarthritisaffectingthesternoxiphoidjoint
‡A
Psoriatic arthritis affecting the sternoxiphoid joint
‡9
1
|
|
919
|
|
|
‡a
psoriasishowtheepitheliuminfluencestheimmuneresponsekeratinocytesdendriticcellsandtlymphocytes
‡A
[Psoriasis: how the epithelium influences the immune response: keratinocytes, dendritic cells and T lymphocytes]
‡9
1
|
|
919
|
|
|
‡a
productionofalymphocytedifferentiatingfactoreldifbyculturedhumanepidermalcells
‡A
Production of a lymphocyte differentiating factor (ELDIF) by cultured human epidermal cells
‡9
1
|
|
919
|
|
|
‡a
productionofalymphocytedifferentiatingfactor
‡A
Production of a lymphocyte differentiating factor
‡9
1
|
|
919
|
|
|
‡a
preventionofnonsteroidalinflammatorydruginducedurticariaandorangioedema
‡A
Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema.
‡9
1
|
|
919
|
|
|
‡a
preventionofaspirininducedangioedemawithanassociationofleukotrieneinhibitorsandantihistamines
‡A
Prevention of aspirin-induced angioedema with an association of leukotriene inhibitors and antihistamines
‡9
1
|
|
919
|
|
|
‡a
porphyriacutaneatardainapatientundergoingbonemarrowtransplantadditionofchroniccyt Omega lovirushepatitisandmultiplehepaticaggressions
‡A
[Porphyria cutanea tarda in a patient undergoing bone marrow transplant. Addition of chronic cyt Omega lovirus hepatitis and multiple hepatic aggressions]
‡9
1
|
|
919
|
|
|
‡a
porphyriacutaneatardaafterallogeneicbonemarrowtransplantationforchronicmyelogenousleukemia
‡A
Porphyria cutanea tarda after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
‡9
1
|
|
919
|
|
|
‡a
pityriasislichenoideschronicainducedbyadalimumabtherapyforcrohnsdiseasereportof2casessuccessfullytreatedwithmethotrexate
‡A
Pityriasis lichenoides chronica induced by adalimumab therapy for Crohn's disease: report of 2 cases successfully treated with methotrexate
‡9
1
|
|
919
|
|
|
‡a
physiopathologyofeczema
‡A
[Physiopathology of eczema]
‡9
1
|
|
919
|
|
|
‡a
physiopathologyofatopicdermatitis
‡A
[Physiopathology of atopic dermatitis]
‡9
1
|
|
919
|
|
|
‡a
photoageingshowshistologicalfeaturesofchronicskininflammationwithoutclinicalandmolecularabnormalities
‡A
Photoageing shows histological features of chronic skin inflammation without clinical and molecular abnormalities
‡9
1
|
|
919
|
|
|
‡a
peripheralnaturalkillercellsexhibitqualitativeandquantitativechangesinpatientswithpsoriasisandatopicdermatitis
‡A
Peripheral natural killer cells exhibit qualitative and quantitative changes in patients with psoriasis and atopic dermatitis
‡9
1
|
|
919
|
|
|
‡a
pemphigusfromclinicalobservationtomolecularbiology
‡A
[Pemphigus: from clinical observation to molecular biology]
‡9
1
|
|
919
|
|
|
‡a
pemphigoidmimickingepidermolysisbullosaacquisita
‡A
[Pemphigoid mimicking epidermolysis bullosa acquisita]
‡9
1
|
|
919
|
|
|
‡a
pemphigoidgestationiswithautoantibodiesexclusivelydirectedtothe230kdabullouspemphigoidantigenbp230ag
‡A
Pemphigoid gestationis with autoantibodies exclusively directed to the 230-kDa bullous pemphigoid antigen (BP230Ag)
‡9
1
|
|
919
|
|
|
‡a
pemphigoidgestationiswithautoantibodiesexclusivelydirectedtothe230kdabullouspemphigoidantigen
‡A
Pemphigoid gestationis with autoantibodies exclusively directed to the 230-kDa bullous pemphigoid antigen
‡9
1
|
|
919
|
|
|
‡a
pathophysiologyofurticariaandtherapeuticapproaches
‡A
[Pathophysiology of urticaria and therapeutic approaches]
‡9
1
|
|
919
|
|
|
‡a
pathophysiologyofurticaria
‡A
[Pathophysiology of urticaria]
‡9
1
|
|
919
|
|
|
‡a
pathogenesisofatopicdermatitis
‡A
[Pathogenesis of atopic dermatitis]
‡9
1
|
|
919
|
|
|
‡a
patchtestinginatopicdermatitispatients
‡A
Patch testing in atopic dermatitis patients.
‡9
1
|
|
919
|
|
|
‡a
patchprickorintradermalteststodetectdelayedhypersensitivitytocorticosteroids
‡A
Patch, prick or intradermal tests to detect delayed hypersensitivity to corticosteroids?
‡9
1
|
|
919
|
|
|
‡a
oraladministrationofhapteninhibitsinvivoinductionofspecificcytotoxiccd8+tcellsmediatingtissueinflammationaroleforregulatorycd4+tcells
‡A
Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells
‡9
1
|
|
919
|
|
|
‡a
optimizationofthemouseearswellingtestforinvivoandinvitrostudiesofweakcontactsensitizers
‡A
Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers
‡9
1
|
|
919
|
|
|
‡a
opticneuritisassociatedwithtumornecrosisfactoralfaantagonistsforthetreatmentofpsoriasis
‡A
Optic neuritis associated with tumor necrosis factor-alfa antagonists for the treatment of psoriasis
‡9
1
|
|
919
|
|
|
‡a
occupationalimmediatecontactallergytohydrolysedwheatproteinaftercosmeticexposure
‡A
Occupational immediate contact allergy to hydrolysed wheat protein after cosmetic exposure
‡9
1
|
|
919
|
|
|
‡a
numerationoftcellsubsetsinsarcoidosisusingmonoclonalantibodiesdecreasedlevelsofperipheralbloodtcellsandcellswithsuppressortcellphenotype
‡A
Numeration of T cell subsets in sarcoidosis using monoclonal antibodies: decreased levels of peripheral blood T cells and cells with suppressor T cell phenotype
‡9
1
|
|
919
|
|
|
‡a
nsaidurticariasimilarmanagementtoacuteurticaria
‡A
[NSAID urticaria: Similar management to acute urticaria]
‡9
1
|
|
919
|
|
|
‡a
neitherskintestsnorchallengetestsaresufficienttoprovideformaldiagnosisofdrugallergyorsensitisationadiscussionofthearticle2medicinesofsimilarimputabilityindermaladversedrugreactions2casesthelimitationsof
‡A
[Neither skin tests nor challenge tests are sufficient to provide formal diagnosis of drug allergy or sensitisation. A discussion of the article "Two medicines of similar imputability in dermal adverse drug reactions (two cases): the limitations of
‡9
1
|
|
919
|
|
|
‡a
mucklewellssyndromeanewfamilialcasedemonstrationofabnormalitiesoflymphocytesubpopulations
‡A
[Muckle-Wells syndrome: a new familial case. Demonstration of abnormalities of lymphocyte subpopulations]
‡9
1
|
|
919
|
|
|
‡a
methotrexateversuscyclosporineinadultswithmoderatetosevereatopicdermatitisaphase3randomizednoninferioritytrial
‡A
Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial.
‡9
1
|
|
919
|
|
|
‡a
methotrexateinatopiceczemacommentstoconsensusbasedeuropeanguidelinesfortreatmentofatopiceczemaatopicdermatitisinadultsandchildrenpart2
‡A
Methotrexate in atopic eczema. Comments to: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II
‡9
1
|
|
919
|
|
|
‡a
methotrexateforthetreatmentofadultatopicdermatitis
‡A
Methotrexate for the treatment of adult atopic dermatitis
‡9
1
|
|
919
|
|
|
‡a
methotrexatedoesnotimpedethedevelopmentofcontactallergy
‡A
Methotrexate does not impede the development of contact allergy.
‡9
1
|
|
919
|
|
|
‡a
medicaltreatmentofraynaudssyndrome
‡A
[Medical treatment of Raynaud's syndrome]
‡9
1
|
|
919
|
|
|
‡a
mechanismofmeaslesvirusinducedsuppressionofinflammatoryimmuneresponses
‡A
Mechanism of measles virus-induced suppression of inflammatory immune responses.
‡9
1
|
|
919
|
|
|
‡a
measlesmumpsrubellavaccinationofaneggallergicchildsensitizedtogelatin
‡A
Measles-Mumps-Rubella vaccination of an egg-allergic child sensitized to gelatin
‡9
1
|
|
919
|
|
|
‡a
majorhistocompatibilitycomplexclass1restrictedcd8+tcellsandclass2restrictedcd4+tcellsrespectivelymediateandregulatecontactsensitivitytodinitrofluorobenzene
‡A
Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene
‡9
1
|
|
919
|
|
|
‡a
majorantigenicepitopesofbullouspemphigoid230kdaantigenmapwithinthe100terminalendoftheproteinevidenceusinga55kdarecombinantprotein
‡A
Major antigenic epitopes of bullous pemphigoid 230 kDa antigen map within the C-terminal end of the protein. Evidence using a 55 kDa recombinant protein.
‡9
1
|
|
919
|
|
|
‡a
lysophosphatidylcholineisanaturaladjuvantthatinitiatescellularimmuneresponses
‡A
Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses
‡9
1
|
|
919
|
|
|
‡a
longlastingallergiccontactdermatitistomethylisothiazolinonemisdiagnosedasatopicdermatitis
‡A
Long-lasting allergic contact dermatitis to methylisothiazolinone misdiagnosed as atopic dermatitis
‡9
1
|
|
919
|
|
|
‡a
localizedpemphigoidafterradiotherapy
‡A
[Localized pemphigoid after radiotherapy]
‡9
1
|
|
919
|
|
|
‡a
linearigadermatosisinducedbypenicilling
‡A
[Linear IgA dermatosis induced by penicillin G]
‡9
1
|
|
919
|
|
|
‡a
linearigabullousdermatosiswithigaantibodiesexclusivelydirectedagainstthe180or230kdaepidermalantigens
‡A
Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens
‡9
1
|
|
919
|
|
|
‡a
linearigabullousdermatosiswithautoantibodiestoa290kdantigenofanchoringfibrils
‡A
Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils
‡9
1
|
|
919
|
|
|
‡a
lichenplanuspemphigoides
‡A
[Lichen planus pemphigoides]
‡9
1
|
|
919
|
|
|
‡a
levomepromazineinducedperipheraledema
‡A
Levomepromazine-induced peripheral edema
‡9
1
|
|
919
|
|
|
‡a
lamininsviaheparansulfateproteoglycansparticipateinzebrafishmyotomemorphogenesisbymodulatingthepatternofbmpresponsiveness
‡A
Laminins, via heparan sulfate proteoglycans, participate in zebrafish myotome morphogenesis by modulating the pattern of Bmp responsiveness.
‡9
1
|
|
919
|
|
|
‡a
laminariaochroleucaextractreducesskininflammation
‡A
Laminaria ochroleuca extract reduces skin inflammation
‡9
1
|
|
919
|
|
|
‡a
lackoforaltolerancebutoralprimingforcontactsensitivitytodinitrofluorobenzeneinmajorhistocompatibilitycomplexclass2deficientmiceandincd4+tcelldepletedmice
‡A
Lack of oral tolerance but oral priming for contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice
‡9
1
|
|
919
|
|
|
‡a
keratinocytefibroblastinteractions1productionbythekeratinocytesofsolublefactorsstimulatingtheproliferationofnormalhumanskinfibroblasts
‡A
Keratinocyte-fibroblast interactions: I. Production by the keratinocytes of soluble factors stimulating the proliferation of normal human skin fibroblasts
‡9
1
|
|
919
|
|
|
‡a
keratinocytederivedsolublefactorswhichinfluencelymphocyteproliferation
‡A
Keratinocyte derived soluble factors which influence lymphocyte proliferation
‡9
1
|
|
919
|
|
|
‡a
kaposissarcomainapatientwithrheumatoidarthritispossibleresponsibilityofcaptoprilinthedevelopmentoflesions
‡A
Kaposi's sarcoma in a patient with rheumatoid arthritis possible responsibility of captopril in the development of lesions
‡9
1
|
|
919
|
|
|
‡a
jeanthivolet
‡A
Jean Thivolet.
‡9
1
|
|
919
|
|
|
‡a
isolatedarthritisofthesternalmanubriumandpalmoplantarpustularpsoriasis
‡A
[Isolated arthritis of the sternal manubrium and palmo-plantar pustular psoriasis]
‡9
1
|
|
919
|
|
|
‡a
istherealinkbetweenchronicurticariaandatopy
‡A
Is there a link between chronic urticaria and atopy?
‡9
1
|
|
919
|
|
|
‡a
intraindividualcomparisonofthecutaneoussafetyandefficacyofcalcitriol3microgg1ointmentandcalcipotriol50microgg1ointmentonchronicplaquepsoriasislocalizedinfacialhairlineretroauricularorflexuralareas
‡A
Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
‡9
1
|
|
919
|
|
|
‡a
interleukin6innormalskinandpsoriasis
‡A
Interleukin-6 in normal skin and psoriasis
‡9
1
|
|
919
|
|
|
‡a
interleukin4stimulatescollagensynthesisbynormalandsclerodermafibroblastsindermalequivalents
‡A
Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents
‡9
1
|
|
919
|
|
|
‡a
interleukin4stimulatescollagengeneexpressioninhumanfibroblastmonolayerculturespotentialroleinfibrosis
‡A
Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. Potential role in fibrosis
‡9
1
|
|
919
|
|
|
‡a
interleukin2immunotherapyandcutaneousmanifestations
‡A
[Interleukin-2 immunotherapy and cutaneous manifestations]
‡9
1
|
|
919
|
|
|
‡a
interleukin1betastimulatesfibroblastelastaseactivity
‡A
Interleukin-1 beta stimulates fibroblast elastase activity
‡9
1
|
|
919
|
|
|
‡a
interferongammaproductioninskinduringcontacthypersensitivitynocontributionfromkeratinocytes
‡A
Interferon-gamma production in skin during contact hypersensitivity. No contribution from keratinocytes
‡9
1
|
|
919
|
|
|
‡a
innatecd4+cd25+regulatorytcellsarerequiredfororaltoleranceandinhibitionofcd8+tcellsmediatingskininflammation
‡A
Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation.
‡9
1
|
|
919
|
|
|
‡a
inhibitorycheckpointreceptorscontrolcd8+residentmemorytcellstopreventskinallergy
‡A
Inhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergy
‡9
1
|
|
919
|
|
|
‡a
induciblecostimulatoricosisamarkerforhighlysuppressiveantigenspecifictcellssharingfeaturesofth17th1andregulatorytcells
‡A
Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
‡9
1
|
|
919
|
|
|
‡a
invitrotcellresponsetostaphylococcalenterotoxinbsuperantigeninchronicplaquetypepsoriasis
‡A
In vitro T cell response to staphylococcal enterotoxin B superantigen in chronic plaque type psoriasis.
‡9
1
|
|
919
|
|
|
‡a
insitupreferentialusageof5 Alpha 8tcellreceptorgenesegmentsinapatientwithbullouspemphigoid
‡A
In-situ preferential usage of V Alpha 8 T-cell receptor gene segments in a patient with bullous pemphigoid
‡9
1
|
|
919
|
|
|
‡a
immunosuppressiveantimetabolitesinhibitinductionofcontacthypersensitivitywhilelymphoablativedrugsalsopreventitsexpression
‡A
Immunosuppressive antimetabolites inhibit induction of contact hypersensitivity while lymphoablative drugs also prevent its expression.
‡9
1
|
|
919
|
|
|
‡a
immunoprotectionbypolyethyleneglycolinorganpreservationsolutionsisnotduetoanimmunomaskingeffect
‡A
Immunoprotection by polyethylene glycol in organ preservation solutions is not due to an immunomasking effect
‡9
1
|
|
919
|
|
|
‡a
immunomodulatingagentsindermatology
‡A
Immunomodulating agents in dermatology
‡9
1
|
|
919
|
|
|
‡a
immunologicalandnonimmunologicalmechanismsinurticaria
‡A
Immunological and non immunological mechanisms in urticaria
‡9
1
|
|
919
|
|
|
‡a
immunointerventioninpsoriasispathogenicconsequences
‡A
[Immunointervention in psoriasis. Pathogenic consequences]
‡9
1
|
|
919
|
|
|
‡a
immunohistopathologicalstudyofautoimmunepemphiguslackofstrictlyspecifichistologicalandindirectimmunofluorescencecriteriaforparaneoplasticpemphigus
‡A
Immunohistopathological study of autoimmune pemphigus. Lack of strictly specific histological and indirect immunofluorescence criteria for paraneoplastic pemphigus
‡9
1
|
|
919
|
|
|
‡a
immunogenicityandsafetyofintradermalinfluenzavaccinationinrenaltransplantpatientswhowerenonresponderstoconventionalinfluenzavaccination
‡A
Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination
‡9
1
|
|
919
|
|
|
‡a
immunofluorescencetechniquesappliedtothediagnosisofautoimmunebullousskindiseasesofthedermoepidermaljunction
‡A
[Immunofluorescence techniques applied to the diagnosis of autoimmune bullous skin diseases of the dermoepidermal junction]
‡9
1
|
|
919
|
|
|
‡a
immediatereactionstolocalanestheticsdiagnosticandtherapeuticprocedures
‡A
[Immediate reactions to local anesthetics: diagnostic and therapeutic procedures]
‡9
1
|
|
919
|
|
|
‡a
immediatehypersensitivityisrarelyimplicatedindruginducedurticaria
‡A
Immediate hypersensitivity is rarely implicated in drug induced urticaria
‡9
1
|
|
919
|
|
|
‡a
1βinducesthymicstromallymphopoietinandanatopicdermatitislikephenotypeinreconstructedhealthyhumanepidermis
‡A
IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis
‡9
1
|
|
919
|
|
|
‡a
igeautoantibodiesdirectedagainstthemajorbullouspemphigoidantigeninpatientswithasevereformofpemphigoid
‡A
IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid
‡9
1
|
|
919
|
|
|
‡a
igeantibodiesinserafrompatientswithbullouspemphigoidareautoantibodiespreferentiallydirectedagainstthe230kdaepidermalantigenbp230
‡A
IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)
‡9
1
|
|
919
|
|
|
‡a
igeantibodiesinserafrompatientswithbullouspemphigoidareautoantibodiespreferentiallydirectedagainstthe230kdaepidermalantigen
‡A
IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen
‡9
1
|
|
919
|
|
|
‡a
identificationofa168kdamucosalantigeninasubsetofpatientswithcicatricialpemphigoid
‡A
Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid
‡9
1
|
|
919
|
|
|
‡a
humantcellprimingassaydepletionofperipheralbloodlymphocytesincd25+cellsimprovestheinvitrodetectionofweakallergenspecifictcells
‡A
Human T cell priming assay: depletion of peripheral blood lymphocytes in CD25(+) cells improves the in vitro detection of weak allergen-specific T cells.
‡9
1
|
|
919
|
|
|
‡a
humanmonoclonalautoantibodiesspecificforthebullouspemphigoidantigen1bpag1
‡A
Human monoclonal autoantibodies specific for the bullous pemphigoid antigen 1 (BPAg 1)
‡9
1
|
|
919
|
|
|
‡a
humanmonoclonalautoantibodiesspecificforthebullouspemphigoidantigen1
‡A
Human monoclonal autoantibodies specific for the bullous pemphigoid antigen 1
‡9
1
|
|
919
|
|
|
‡a
howtounderstandpsoriasis
‡A
[How to understand psoriasis?]
‡9
1
|
|
919
|
|
|
‡a
histaminergicangioedemaandchronicurticaria
‡A
[Histaminergic angioedema and chronic urticaria]
‡9
1
|
|
943
|
|
|
‡a
201x
‡A
2011
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
BNE|XX947717
|
|
996
|
|
|
‡2
ISNI|0000000513511966
|
|
996
|
|
|
‡2
SUDOC|07036575X
|
|
996
|
|
|
‡2
SUDOC|136318452
|
|
996
|
|
|
‡2
BNF|13527919
|
|
996
|
|
|
‡2
DNB|12555141X
|
|
996
|
|
|
‡2
ISNI|0000000116586999
|
|
996
|
|
|
‡2
DNB|1235262669
|
|
996
|
|
|
‡2
BAV|495_234997
|
|
996
|
|
|
‡2
BNE|XX6329536
|
|
996
|
|
|
‡2
ISNI|0000000483376328
|
|
996
|
|
|
‡2
ISNI|0000000364487586
|
|
996
|
|
|
‡2
NUKAT|n 2021082821
|
|
996
|
|
|
‡2
BNF|13603553
|
|
996
|
|
|
‡2
BNC|981058615820506706
|
|
996
|
|
|
‡2
LC|n 78059653
|
|
996
|
|
|
‡2
ISNI|0000000357424130
|
|
996
|
|
|
‡2
SUDOC|267200552
|
|
996
|
|
|
‡2
PTBNP|85450
|
|
996
|
|
|
‡2
NUKAT|nx2022514481
|
|
996
|
|
|
‡2
RERO|A003639545
|
|
996
|
|
|
‡2
BNF|14420048
|
|
996
|
|
|
‡2
LC|no2018098009
|
|
996
|
|
|
‡2
SUDOC|197451292
|
|
996
|
|
|
‡2
SUDOC|158602234
|
|
996
|
|
|
‡2
NSK|000128597
|
|
996
|
|
|
‡2
LC|nr 98029944
|
|
996
|
|
|
‡2
BNC|981058529676106706
|
|
996
|
|
|
‡2
LC|n 86144484
|
|
996
|
|
|
‡2
SUDOC|27388820X
|
|
996
|
|
|
‡2
SUDOC|02704761X
|
|
996
|
|
|
‡2
SUDOC|18951129X
|
|
996
|
|
|
‡2
LC|no2003068105
|
|
996
|
|
|
‡2
LC|no2004103705
|
|
996
|
|
|
‡2
SUDOC|177315016
|
|
996
|
|
|
‡2
NKC|xx0215943
|
|
996
|
|
|
‡2
PLWABN|9810613117705606
|
|
996
|
|
|
‡2
ISNI|0000000431487923
|
|
996
|
|
|
‡2
BIBSYS|90259458
|
|
996
|
|
|
‡2
RERO|A003639532
|
|
996
|
|
|
‡2
PTBNP|643177
|
|
996
|
|
|
‡2
DNB|1146238681
|
|
996
|
|
|
‡2
BNCHL|10000000000000000165137
|
|
996
|
|
|
‡2
ISNI|0000000385531785
|
|
996
|
|
|
‡2
SUDOC|234121017
|
|
996
|
|
|
‡2
ISNI|0000000389589415
|
|
996
|
|
|
‡2
RERO|A012329838
|
|
996
|
|
|
‡2
ISNI|0000000459791759
|
|
996
|
|
|
‡2
BNE|XX1515689
|
|
996
|
|
|
‡2
DNB|1157209955
|
|
996
|
|
|
‡2
BIBSYS|90392248
|
|
996
|
|
|
‡2
ISNI|000000012056547X
|
|
996
|
|
|
‡2
ISNI|0000000504112162
|
|
996
|
|
|
‡2
BNF|13056495
|
|
996
|
|
|
‡2
CAOONL|ncf11226377
|
|
996
|
|
|
‡2
SUDOC|266629156
|
|
996
|
|
|
‡2
ISNI|0000000401607373
|
|
996
|
|
|
‡2
ISNI|0000000120981166
|
|
996
|
|
|
‡2
SUDOC|250732157
|
|
996
|
|
|
‡2
BNE|XX981126
|
|
996
|
|
|
‡2
RERO|A003639548
|
|
996
|
|
|
‡2
RERO|A003639546
|
|
996
|
|
|
‡2
BNE|XX877361
|
|
996
|
|
|
‡2
RERO|A003639544
|
|
996
|
|
|
‡2
ISNI|0000000435410149
|
|
996
|
|
|
‡2
ISNI|0000000059451771
|
|
996
|
|
|
‡2
SUDOC|229882420
|
|
996
|
|
|
‡2
SUDOC|137968086
|
|
996
|
|
|
‡2
LC|no2007012734
|
|
996
|
|
|
‡2
ISNI|0000000431202123
|
|
996
|
|
|
‡2
SUDOC|169170926
|
|
996
|
|
|
‡2
LC|no2011076604
|
|
996
|
|
|
‡2
PLWABN|9810653601305606
|
|
996
|
|
|
‡2
ISNI|0000000434851006
|
|
996
|
|
|
‡2
ISNI|0000000048946525
|
|
996
|
|
|
‡2
LC|n 82057333
|
|
996
|
|
|
‡2
SUDOC|241569885
|
|
996
|
|
|
‡2
BNE|XX1607944
|
|
996
|
|
|
‡2
J9U|987007354261605171
|
|
996
|
|
|
‡2
NII|DA15588074
|
|
996
|
|
|
‡2
LC|ns2018001726
|
|
996
|
|
|
‡2
LC|nb2014004135
|
|
996
|
|
|
‡2
DNB|188375228
|
|
996
|
|
|
‡2
BNF|12153819
|
|
996
|
|
|
‡2
NSK|000387673
|
|
996
|
|
|
‡2
BIBSYS|98059372
|
|
996
|
|
|
‡2
NUKAT|n 2002018878
|
|
996
|
|
|
‡2
RERO|A013129039
|
|
996
|
|
|
‡2
ISNI|0000000374297858
|
|
996
|
|
|
‡2
DNB|103753719X
|
|
996
|
|
|
‡2
SUDOC|240591356
|
|
996
|
|
|
‡2
SUDOC|262216477
|
|
996
|
|
|
‡2
BNC|981058525269006706
|
|
996
|
|
|
‡2
LC|n 2013180941
|
|
996
|
|
|
‡2
SUDOC|233076964
|
|
996
|
|
|
‡2
SUDOC|033036179
|
|
996
|
|
|
‡2
ISNI|0000000459565209
|
|
996
|
|
|
‡2
RERO|A011393605
|
|
996
|
|
|
‡2
BNF|12394365
|
|
996
|
|
|
‡2
ISNI|0000000023243188
|
|
996
|
|
|
‡2
NTA|142091316
|
|
996
|
|
|
‡2
SUDOC|175662576
|
|
996
|
|
|
‡2
BNC|981058615820806706
|
|
996
|
|
|
‡2
LC|n 92108691
|
|
996
|
|
|
‡2
ISNI|0000000511240760
|
|
996
|
|
|
‡2
SUDOC|030041392
|
|
996
|
|
|
‡2
DNB|1056596333
|
|
996
|
|
|
‡2
DNB|133056902
|
|
996
|
|
|
‡2
SUDOC|061401935
|
|
996
|
|
|
‡2
CAOONL|ncf10376348
|
|
996
|
|
|
‡2
NII|DA08961790
|
|
996
|
|
|
‡2
B2Q|0000324816
|
|
996
|
|
|
‡2
ICCU|PUVV047506
|
|
996
|
|
|
‡2
SUDOC|132150050
|
|
996
|
|
|
‡2
DNB|140914935
|
|
996
|
|
|
‡2
DNB|1157898343
|
|
996
|
|
|
‡2
LC|n 85221455
|
|
996
|
|
|
‡2
SUDOC|156666707
|
|
996
|
|
|
‡2
J9U|987007328507805171
|
|
996
|
|
|
‡2
RERO|A012445934
|
|
996
|
|
|
‡2
SUDOC|029958067
|
|
996
|
|
|
‡2
SUDOC|271486880
|
|
996
|
|
|
‡2
ISNI|0000000000851455
|
|
996
|
|
|
‡2
SUDOC|262088614
|
|
996
|
|
|
‡2
ISNI|0000000460789752
|
|
996
|
|
|
‡2
ISNI|0000000392137356
|
|
996
|
|
|
‡2
J9U|987007319434305171
|
|
996
|
|
|
‡2
NII|DA13141016
|
|
996
|
|
|
‡2
ISNI|0000000060224760
|
|
996
|
|
|
‡2
SUDOC|157231461
|
|
996
|
|
|
‡2
SUDOC|055287646
|
|
996
|
|
|
‡2
LC|no2009018189
|
|
996
|
|
|
‡2
ISNI|0000000071300175
|
|
996
|
|
|
‡2
LC|n 90713174
|
|
996
|
|
|
‡2
BNC|981058513746706706
|
|
996
|
|
|
‡2
BNF|16187638
|
|
996
|
|
|
‡2
ISNI|0000000059797123
|
|
996
|
|
|
‡2
ISNI|0000000502623882
|
|
996
|
|
|
‡2
BNF|17746897
|
|
996
|
|
|
‡2
NII|DA1694072X
|
|
996
|
|
|
‡2
ISNI|0000000431994861
|
|
996
|
|
|
‡2
LC|n 2010046523
|
|
996
|
|
|
‡2
RERO|A009548519
|
|
996
|
|
|
‡2
RERO|A000122053
|
|
996
|
|
|
‡2
NUKAT|n 2006001934
|
|
996
|
|
|
‡2
BNF|17945635
|
|
996
|
|
|
‡2
ISNI|000000006096091X
|
|
996
|
|
|
‡2
BNF|16638056
|
|
996
|
|
|
‡2
BNE|XX876344
|
|
996
|
|
|
‡2
LC|n 85815228
|
|
996
|
|
|
‡2
ISNI|0000000000671278
|
|
996
|
|
|
‡2
PLWABN|9810577701205606
|
|
996
|
|
|
‡2
RERO|A012874404
|
|
996
|
|
|
‡2
DNB|1023774410
|
|
996
|
|
|
‡2
BNE|XX1001035
|
|
996
|
|
|
‡2
ISNI|0000000116964195
|
|
996
|
|
|
‡2
NUKAT|n 99041828
|
|
996
|
|
|
‡2
SUDOC|08115822X
|
|
996
|
|
|
‡2
SUDOC|167924109
|
|
996
|
|
|
‡2
DNB|1188626612
|
|
996
|
|
|
‡2
BNF|13093373
|
|
996
|
|
|
‡2
SUDOC|084610719
|
|
996
|
|
|
‡2
J9U|987007327975205171
|
|
996
|
|
|
‡2
DNB|1136613722
|
|
996
|
|
|
‡2
PLWABN|9810644155105606
|
|
996
|
|
|
‡2
BNE|XX5855211
|
|
996
|
|
|
‡2
NUKAT|n 01022228
|
|
996
|
|
|
‡2
ISNI|0000000000988443
|
|
996
|
|
|
‡2
ISNI|0000000513512782
|
|
996
|
|
|
‡2
SUDOC|034726349
|
|
996
|
|
|
‡2
PLWABN|9810603340705606
|
|
996
|
|
|
‡2
BNCHL|10000000000000000080498
|
|
996
|
|
|
‡2
ISNI|000000007589242X
|
|
996
|
|
|
‡2
ISNI|0000000014607138
|
|
996
|
|
|
‡2
DNB|124383963
|
|
996
|
|
|
‡2
NII|DA04815990
|
|
996
|
|
|
‡2
NTA|242380999
|
|
996
|
|
|
‡2
NTA|425885569
|
|
996
|
|
|
‡2
SUDOC|129953768
|
|
996
|
|
|
‡2
ISNI|0000000006893824
|
|
996
|
|
|
‡2
CAOONL|ncf12059305
|
|
996
|
|
|
‡2
ISNI|0000000117390971
|
|
996
|
|
|
‡2
BNF|12147303
|
|
996
|
|
|
‡2
BNF|17089487
|
|
996
|
|
|
‡2
SUDOC|075896311
|
|
996
|
|
|
‡2
BNF|12147309
|
|
996
|
|
|
‡2
RERO|A003640028
|
|
996
|
|
|
‡2
LC|n 87822605
|
|
996
|
|
|
‡2
LC|no2003121798
|
|
996
|
|
|
‡2
BNF|12147196
|
|
996
|
|
|
‡2
RERO|A013276184
|
|
996
|
|
|
‡2
SUDOC|195421639
|
|
996
|
|
|
‡2
SUDOC|138953694
|
|
996
|
|
|
‡2
DNB|13795400X
|
|
996
|
|
|
‡2
BNF|11917668
|
|
996
|
|
|
‡2
ISNI|0000000483072930
|
|
996
|
|
|
‡2
SUDOC|275841596
|
|
996
|
|
|
‡2
CAOONL|ncf11774752
|
|
996
|
|
|
‡2
NUKAT|n 00030458
|
|
996
|
|
|
‡2
CAOONL|ncf11177547
|
|
996
|
|
|
‡2
LC|n 82027700
|
|
996
|
|
|
‡2
ISNI|0000000459706606
|
|
996
|
|
|
‡2
CAOONL|ncf11368667
|
|
996
|
|
|
‡2
SUDOC|140756973
|
|
996
|
|
|
‡2
SUDOC|197574033
|
|
996
|
|
|
‡2
SUDOC|058579001
|
|
996
|
|
|
‡2
SUDOC|136752446
|
|
996
|
|
|
‡2
BNE|XX1034608
|
|
996
|
|
|
‡2
NTA|258112719
|
|
996
|
|
|
‡2
SUDOC|258812656
|
|
997
|
|
|
‡a
1955 0 lived 0000 0
‡9
1
|
|
998
|
|
|
‡a
Nicolas, Jean-François
‡2
ISNI|0000000116586999
‡3
suggested
|
|
998
|
|
|
‡a
Nicolas, Jean-François
‡2
ISNI|0000000116586999
‡3
suggested
|
|
998
|
|
|
‡a
Nicolas, Jean-François,
‡c
en poste à l'Inserm à Paris
‡2
SUDOC|070162956
‡3
title: (0.95, 'decreasedexpressionofkeratinocytess1integrinsinchronicallysunexposedskininvivo', 'decreasedexpressionofkeratinocytebeta1integrinsinchronicallysunexposedskininvivo')
|
|
998
|
|
|
‡a
Nicolas, Jean-François.
‡2
NUKAT|n 01022228
‡3
viafid
|
|
998
|
|
|
‡a
Nicolas, Jean-François,
‡c
dermatologue
‡2
SUDOC|035185201
‡3
suggested
‡3
title: (0.67, 'physiopathologyofcutaneousinflammationroleoftheskininnateimmunityinthedevelopmentofallergiccontactdermatitis', 'allergiccontactdermatitis')
|
|
998
|
|
|
‡a
Nicolas
‡b
Jean-François
‡2
BNF|13172675
‡3
title: (0.67, 'physiopathologiedupsoriasis', 'tnf Alpha inthephysiopathologyofpsoriasis')
|
